Drug and Alcohol Screening Market Report 2026

The drug and alcohol screening market size has grown rapidly in recent years. It will grow from $9.54 billion in 2025 to $10.99 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to expansion of workplace drug testing policies, increasing regulatory enforcement, growth of forensic testing demand, adoption of standardized testing protocols, availability of diversified sample testing methods.

The drug and alcohol screening market size is expected to see rapid growth in the next few years. It will grow to $19.16 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for real-time testing solutions, rising integration of digital reporting systems, expansion of workplace safety regulations, growing use of non-invasive testing methods, increasing focus on data integrity and compliance. Major trends in the forecast period include increasing adoption of rapid and on-site testing solutions, rising use of automated laboratory screening systems, growing deployment of digital result management platforms, expansion of workplace compliance testing programs, enhanced focus on accuracy and turnaround time.

The rising use of narcotics and illegal drugs is expected to drive the growth of the drug and alcohol screening market in the coming years. Narcotics and illegal drugs are substances that affect the central nervous system and are often consumed for their pain-relieving or mind-altering effects. Their use is increasing as more individuals turn to substances to cope with mental health challenges such as anxiety, depression, and trauma. Drug and alcohol screening supports the mitigation of narcotics and illegal drug use by enabling early detection, ensuring safety, and facilitating timely interventions in workplaces, healthcare, and legal contexts. For example, in October 2025, the Office for National Statistics in England and Wales reported 5,565 deaths related to drug poisoning in 2024, equivalent to 93.9 deaths per million people, up from 5,448 deaths (93 deaths per million) in 2023. Therefore, the growing use of narcotics and illegal drugs is propelling the expansion of the drug and alcohol screening market.

Leading companies in the drug and alcohol screening market are developing advanced technological solutions, such as alcohol detection software, to improve the accuracy, speed, and reliability of screening processes. Alcohol detection software is a digital solution that collects and manages data from alcohol testing devices, enabling real-time monitoring, automated reporting, and enhanced compliance in safety-critical environments. For instance, in October 2024, Sobrsafe Inc., a US-based behavioral health safety company, launched a fully integrated enterprise software platform for alcohol detection and monitoring in behavioral health settings. The system integrates two products: SOBRcheck for point-of-care screening and SOBRsure for continuous alcohol monitoring. Using advanced touch-based transdermal alcohol detection, it eliminates the need for invasive breath, blood, or urine tests. The software provides real-time visibility across multiple users and locations via a unified dashboard accessible on computers and mobile devices, seamlessly integrating with electronic medical records (EMR).

In May 2024, eMed LLC, a US-based healthcare technology company specializing in at-home and virtual diagnostics, partnered with i3screen to launch a virtual drug screening program for employers. This partnership provides employers with a fully remote, convenient, and instant oral drug screening solution, streamlining and accelerating pre-employment drug testing while maintaining test integrity and compliance. i3screen, based in the US, specializes in screening management systems, including drug and alcohol testing solutions.

Major companies operating in the drug and alcohol screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Drägerwerk AG & Co. KGaA, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., OraSure Technologies Inc., MEDTOX Laboratories Inc., Psychemedics Corporation, SureHire Inc., Alcohol Countermeasure Systems Corp., Phamatech Inc., Premier Biotech Inc., Alfa Scientific Designs Inc., Omega Laboratories Inc., Lifeloc Technologies Inc., Smartox Biotechnology SAS, Millennium Health LLC, Aegis Sciences Corporation, Cordant Health Solutions Inc., Intoximeters Inc.

North America was the largest region in the drug and alcohol screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug and alcohol screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug and alcohol screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the drug and alcohol screening market by increasing costs of imported testing kits, analytical instruments, sensors, reagents, and laboratory equipment used across urine, oral fluid, and hair testing. Testing laboratories and healthcare facilities in North America and Europe are most affected due to reliance on imported diagnostic supplies, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising testing service prices and procurement expenses. However, they are also encouraging domestic production of test kits, regional reagent manufacturing, and increased innovation in cost-efficient rapid screening technologies.

The drug and alcohol screening market research report is one of a series of new reports that provides drug and alcohol screening market statistics, including drug and alcohol screening industry global market size, regional shares, competitors with a drug and alcohol screening market share, detailed drug and alcohol screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug and alcohol screening industry. This drug and alcohol screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Drug and alcohol screening is a systematic process used to detect and quantify the presence of drugs or alcohol in an individual’s system through scientifically validated testing methods. This process is essential for ensuring safety, enforcing regulatory compliance, and supporting informed decision-making across personal, professional, and legal contexts.

The primary types of samples used in drug and alcohol screening include urine, oral fluid, hair, and others. Urine samples are one of the most commonly used biological specimens, collected to detect drugs, alcohol, or their metabolites. They provide a non-invasive, cost-effective method for detecting short-term substance use. These tests are applied in workplaces, criminal justice and law enforcement systems, drug treatment centers, pain management facilities, and drug testing laboratories, serving a wide range of end users, including hospitals and treatment centers, law enforcement agencies, sporting events, and more.

The drug and alcohol screening market includes revenues earned by entities by providing services, such as pre-employment screening, random testing, reasonable suspicion testing, rehabilitation and monitoring programs, and follow-up testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.